CFAI
C.F.A.I.
Government Data Intelligence Services

Bionpharma Inc.

Company NJ
Found in 2 federal databases · 6 total records
fda 2 records
FDA Drug Recall: Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed 2024-10-23
Class I — Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.
View Source
FDA Drug Recall: Clobazam Oral Suspension, 2.5 mg/mL, 120 mL bottle, Rx only, Distributed by: Bio 2019-07-31
Class II — Microbial Contamination of Non-Sterile Products: Out-of-specification results for Microbial Enumeration Tests USP <61> was observed.
View Source
fda_adverse 4 records
FDA AE Manufacturer: Bionpharma Inc.
Drug adverse event reporter — Product: ACYCLOVIR
View Source
FDA AE Manufacturer: Bionpharma Inc.,
Drug adverse event reporter — Product: DEXAMETHASONE
View Source
FDA AE Manufacturer: Bionpharma, Inc.
Drug adverse event reporter — Product: MAGNESIUM CITRATE
View Source
FDA AE Manufacturer: Bionpharma Inc
Drug adverse event reporter — Product: CEVIMELINE HYDROCHLORIDE
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.